PTL suppresses HDACI-mediated NF-κB activation in acute myeloid leukemia (AML) cells while promoting SAPK/JNK and programmed cell death’s gene activation (Mathema et al., 2012). Here, MAPK9 is linked to acute myeloid leukemia.